Clinerion Ltd Contact Details:
Main address: Margarethenstrasse 47 4053 Basel, Switzerland ,
Tel:+41 61 865 60 60 , E-mail: info(at) Website:

Clinerion Patient Network Explorer

Clinerion Patient Network Explorer

Optimized study design, precise site selection and faster patient search and identification for clinical research - in real time.

Clinerion Cookie Policy

Welcome to the Clinerion website. This website uses cookies. These cookies are used on your browser to understand how you are using our website. Using this website means you agree to our use of cookies. If you prefer not to have these cookies on your device, we advise you to disable them in your web browser settings. You accept the use of cookies by accepting this notice. You can read more details via our Privacy Policy page.

Privacy Policy page >

Report: Introduction to Clinerion's technology solutions at Başkent University, Turkey

Clinerion Turkey organized 3 different sessions at Başkent University, Ankara, to introduce Clinerion’s technology solutions.

The main focus was to explain the technology driven processes of the recently established Clinical Trials Center. Principal investigators and study teams can now make data driven feasibility, patient identification and protocol optimization using Clinerion’s technology solutions. Researchers can also leverage the technology to make faster publications. 

The first meeting was held at the Başkent University campus with an audience from Life Sciences and Ethics Committee. The discussions focused on making joint publications with the medical departments by unleashing the potential of Real World Data accumulated at the Başkent University Hospitals. The second and third meetings were held at the Başkent University Hospital. Participants were medical staff of the hospital. With Clinerion’s technology, experience and global presence, Başkent University would like to increase the number of physicians conducting clinical trials, number of trials coming to the hospitals and number of patients having access to innovative drugs. 

We would like to thank the rector of Başkent University Prof. Dr. Ali Haberal and the dean of the medical faculty Prof.Dr. Haldun Müderrisoğlu, for the kind invitation and great support to make this event a success.